About Amgen (AMGN)
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis... Read more
- USD333.65
- USD333.98
- USD330.85
- USD346.38
- -3.40%
- 36.0B
- 792.58k
- 3.12M
- 176.3B
- 257.05
- 26.50%
- 15.70%
Stock News
7 hours ago
A humanoid-robot revolution is coming. Don’t worry — here’s why it will take a while.
MarketWatch
8 hours ago
Precious Metals Plays: GDX Offers Broader Exposure and Less Volatility Than SLVP
Yahoo
10 hours ago
FOMC Minutes, Jobless Claims Report In Focus As 2025 Winds Down
SeekingAlpha
11 hours ago
Be The Bank: I Am Locking In 7% Yields From Corporate And Municipal Borrowers Now
SeekingAlpha